]> 2026-10-17T07:45:45+00:00 Trials (Institut Curie) 0 en Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial Abiraterone Acetate in Molecular Apocrine Breast Cancer A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE) Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009) Transplantation After Complete Response In Patients With T-cell Lymphoma Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma REal World Data in LYmphoma and Survival in Adults Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange DNA Repair Inhibitor & Irradiation on Melanoma Breast Cancer Risk After Diagnostic Gene Sequencing A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Analysis of Circulating Tumor Markers in the Blood (ALCINA) A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE) Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma ProActIF-01 Trial: Randomized Study of Evaluation of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Lung or Digestive Cancers Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax 2025-12-14T18:37:23Z 2461024.2759607 Trials (Institut Curie) Institut Curie 0 en Institut Curie HasClinicalTrial 102 en HasClinicalTrial